Cite

HARVARD Citation

    Wyant, T. et al. (2015). Vedolizumab affects antibody responses to immunisation selectively in the gastrointestinal tract: randomised controlled trial results. Gut. 64 (1), pp. 77-83. [Online]. 
  
Back to record